Record Information
Version1.0
Creation Date2009-07-21 20:26:20 UTC
Update Date2026-05-14 16:24:49 UTC
Accession NumberCHEM002147
Identification
Common NameTemazepam
ClassSmall Molecule
Description
Temazepam is only found in individuals that have used or taken this drug. It is a benzodiazepine that acts as a gamma-aminobutyric acid modulator and anti-anxiety agent. [PubChem]Benzodiazepines bind nonspecifically to benzodiazepine receptors, which affects muscle relaxation, anticonvulsant activity, motor coordination, and memory. As benzodiazepine receptors are thought to be coupled to gamma-aminobutyric acid-A (GABAA) receptors, this enhances the effects of GABA by increasing GABA affinity for the GABA receptor. Binding of the inhibitory neurotransmitter GABA to the site opens the chloride channel, resulting in a hyperpolarized cell membrane that prevents further excitation of the cell.
Contaminant Sources
  • HMDB Contaminants - Urine
  • IARC Carcinogens Group 3
  • STOFF IDENT Compounds
  • T3DB toxins
  • ToxCast & Tox21 Chemicals
Contaminant Type
  • Adjuvant, Anesthesia
  • Amide
  • Amine
  • Anti-Anxiety Agent
  • Benzodiazepine
  • Drug
  • GABA Modulator
  • Human Neurotoxin
  • Hypnotic and Sedative
  • Metabolite
  • Organic Compound
  • Organochloride
  • Synthetic Compound
Chemical Structure
Synonyms
ValueSource
RestorilKegg
HydroxydiazepamHMDB
MethyloxazepamHMDB
N-MethyloxazepamHMDB
OxydiazepamHMDB
Apotex brand OF temazepamMeSH, HMDB
Katwijk brand OF temazepamMeSH, HMDB
Knoll brand OF temazepamMeSH, HMDB
NocturneMeSH, HMDB
NormitabMeSH, HMDB
Novopharm brand OF temazepamMeSH, HMDB
Nu pharm brand OF temazepamMeSH, HMDB
Nu temazepamMeSH, HMDB
Nu-pharm brand OF temazepamMeSH, HMDB
PMS TemazepamMeSH, HMDB
PMS-TemazepamMeSH, HMDB
RemestanMeSH, HMDB
Sigma brand OF temazepamMeSH, HMDB
3 HydroxydiazepamMeSH, HMDB
3-HydroxydiazepamMeSH, HMDB
AHP brand OF temazepamMeSH, HMDB
apo-TemazepamMeSH, HMDB
Genopharm brand OF temazepamMeSH, HMDB
Genpharm brand OF temazepamMeSH, HMDB
Mallinckrodt brand OF temazepamMeSH, HMDB
NortemMeSH, HMDB
novo TemazepamMeSH, HMDB
Nu-temazepamMeSH, HMDB
Orion brand OF temazepamMeSH, HMDB
PlanumMeSH, HMDB
TenoxMeSH, HMDB
Wyeth brand OF temazepamMeSH, HMDB
CT-Arzneimittel brand OF temazepamMeSH, HMDB
apo TemazepamMeSH, HMDB
EuhypnosMeSH, HMDB
ICN brand OF temazepamMeSH, HMDB
NormisonMeSH, HMDB
Norton brand OF temazepamMeSH, HMDB
Novartis brand OF temazepamMeSH, HMDB
Pfizer brand 1 OF temazepamMeSH, HMDB
Pfizer brand 2 OF temazepamMeSH, HMDB
Pharmascience brand OF temazepamMeSH, HMDB
Scheffler brand OF temazepamMeSH, HMDB
SignopamMeSH, HMDB
Tema, norkotralMeSH, HMDB
TemazeMeSH, HMDB
TemtabsMeSH, HMDB
CT Arzneimittel brand OF temazepamMeSH, HMDB
Alphapharm brand OF temazepamMeSH, HMDB
DasuenMeSH, HMDB
Desitin brand OF temazepamMeSH, HMDB
Gen temazepamMeSH, HMDB
Gen-temazepamMeSH, HMDB
LevanxolMeSH, HMDB
Norkotral temaMeSH, HMDB
novo-TemazepamMeSH, HMDB
Pronervon TMeSH, HMDB
Temazep von CTMeSH, HMDB
Von CT, temazepMeSH, HMDB
Chemical FormulaC16H13ClN2O2
Average Molecular Mass300.740 g/mol
Monoisotopic Mass300.067 g/mol
CAS Registry Number846-50-4
IUPAC Name7-chloro-3-hydroxy-1-methyl-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one
Traditional Nametemazepam
SMILESCN1C2=C(C=C(Cl)C=C2)C(=NC(O)C1=O)C1=CC=CC=C1
InChI IdentifierInChI=1/C16H13ClN2O2/c1-19-13-8-7-11(17)9-12(13)14(18-15(20)16(19)21)10-5-3-2-4-6-10/h2-9,15,20H,1H3
InChI KeyInChIKey=SEQDDYPDSLOBDC-UHFFFAOYNA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as 1,4-benzodiazepines. These are organic compounds containing a benzene ring fused to a 1,4-azepine.
KingdomOrganic compounds
Super ClassOrganoheterocyclic compounds
ClassBenzodiazepines
Sub Class1,4-benzodiazepines
Direct Parent1,4-benzodiazepines
Alternative Parents
Substituents
  • 1,4-benzodiazepine
  • Alpha-amino acid or derivatives
  • Aryl chloride
  • Aryl halide
  • Monocyclic benzene moiety
  • Benzenoid
  • Tertiary carboxylic acid amide
  • Carboxamide group
  • Ketimine
  • Lactam
  • Alkanolamine
  • Azacycle
  • Organic 1,3-dipolar compound
  • Propargyl-type 1,3-dipolar organic compound
  • Carboxylic acid derivative
  • Organic nitrogen compound
  • Organohalogen compound
  • Organochloride
  • Imine
  • Organonitrogen compound
  • Organooxygen compound
  • Carbonyl group
  • Hydrocarbon derivative
  • Organic oxide
  • Organopnictogen compound
  • Organic oxygen compound
  • Aromatic heteropolycyclic compound
Molecular FrameworkAromatic heteropolycyclic compounds
External Descriptors
Biological Properties
StatusDetected and Not Quantified
OriginExogenous
Cellular Locations
  • Cytoplasm
  • Membrane
Biofluid LocationsNot Available
Tissue Locations
  • Kidney
  • Liver
PathwaysNot Available
ApplicationsNot Available
Biological RolesNot Available
Chemical RolesNot Available
Physical Properties
StateSolid
AppearanceWhite powder.
Experimental Properties
PropertyValue
Melting Point119-121°C
Boiling PointNot Available
Solubility164 mg/L
Predicted Properties
PropertyValueSource
Water Solubility0.053 g/LALOGPS
logP2.16ALOGPS
logP2.79ChemAxon
logS-3.8ALOGPS
pKa (Strongest Acidic)10.68ChemAxon
pKa (Strongest Basic)-1.4ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count3ChemAxon
Hydrogen Donor Count1ChemAxon
Polar Surface Area52.9 ŲChemAxon
Rotatable Bond Count1ChemAxon
Refractivity81.01 m³·mol⁻¹ChemAxon
Polarizability30.32 ųChemAxon
Number of Rings3ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Spectra
Spectra
Toxicity Profile
Route of ExposureOral, well absorbed, minimal first-pass metabolism.
Mechanism of ToxicityBenzodiazepines bind nonspecifically to benzodiazepine receptors, which affects muscle relaxation, anticonvulsant activity, motor coordination, and memory. As benzodiazepine receptors are thought to be coupled to gamma-aminobutyric acid-A (GABAA) receptors, this enhances the effects of GABA by increasing GABA affinity for the GABA receptor. Binding of the inhibitory neurotransmitter GABA to the site opens the chloride channel, resulting in a hyperpolarized cell membrane that prevents further excitation of the cell.
MetabolismHepatic. Temazepam is completely metabolized through conjugation prior to excretion. The major metabolite is the O-conjugate of temazepam (90%). Route of Elimination: Temazepam was completely metabolized through conjugation prior to excretion; 80% to 90% of the dose appeared in the urine. Half Life: 10-20 hours
Toxicity ValuesLD50: 1963 mg/kg (oral, mice) (7) LD50: 1833 mg/kg (oral, rat) (7) LD50: >2400 mg/kg (oral, rabbit) (7)
Lethal DoseNot Available
Carcinogenicity (IARC Classification)3, not classifiable as to its carcinogenicity to humans. (6)
Uses/SourcesOfficially indicated for severe insomnia and other severe or disabling sleep disorders. For the short-term treatment of insomnia (generally 7-10 days).
Minimum Risk LevelNot Available
Health EffectsThey cause slurred speech, disorientation and "drunken" behavior. They are physically and psychologically addictive.
SymptomsNot Available
TreatmentIf the patient is conscious, vomiting should be induced mechanically or with emetics. Gastric lavage should be employed utilizing concurrently a cuffed endotracheal tube if the patient is unconscious to prevent aspiration and pulmonary complications. Maintenance of adequate pulmonary ventilation is essential. The use of pressor agents intravenously may be necessary to combat hypotension. Fluids should be administered intravenously to encourage diuresis. (8)
Concentrations
Not Available
External Links
DrugBank IDDB00231
HMDB IDHMDB0259493
FooDB IDNot Available
Phenol Explorer IDNot Available
KNApSAcK IDNot Available
BiGG IDNot Available
BioCyc IDNot Available
METLIN IDNot Available
PDB IDNot Available
Wikipedia LinkTemazepam
Chemspider ID5198
ChEBI IDNot Available
PubChem Compound IDNot Available
Kegg Compound IDC07125
YMDB IDNot Available
ECMDB IDNot Available
References
Synthesis ReferenceNot Available
MSDSNot Available
General References